• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Liposomal codelivery of inflammation inhibitor and collagen protector to the plaque for effective anti-atherosclerosis

    2023-03-14 06:52:14XiaotongLiJiayiGuQingqingXiaoYingLiuPingZhouLifangFanXiulianZhangXiangLuJunWuZhngxiaLiuWi
    Chinese Chemical Letters 2023年1期

    Xiaotong Li,Jiayi Gu,Qingqing Xiao,Ying Liu,Ping Zhou,Lifang Fan,Xiulian Zhang,Xiang Lu,g,Jun Wu,Zhngxia Liu,**,Wi H

    a School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China

    b Department of Geriatrics,The Second Affiliated Hospital,Nanjing Medical University,Nanjing 210011,China

    c Key Laboratory for Aging & Disease,Nanjing Medical University,Nanjing 210011,China

    d Jiangsu Aosaikang Pharmaceutical Co.,Ltd.,Nanjing 211112,China

    e Department of Respiratory Disease,Baoshan Branch,Shuguang Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200120,China

    f Department of Geriatric Cardiology,Jiangsu Provincial Key Laboratory of Geriatrics,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China

    g Department of Geriatrics,The Affiliated Sir Run Run Hospital of Nanjing Medical University,Nanjing 211166,China

    Keywords:Atherosclerosis Plaque Inflammation Collagen Macrophages Co-delivery Liposomes

    ABSTRACT Plaque plays a central role in atherosclerosis (AS) progression,whereas inflammation and destruction of the plaque microenvironment contribute to plaque advancement.As a result,a therapy regime,which combines anti-inflammation and inhibition-degradation of plaque matrix,appears to be a promising strategy to combat AS.Herein,we report a pH-sensitive liposome co-loading with the anti-inflammatory agent(oridonin,ORD) and plaque-collagen protector (marimastat) for anti-AS therapy.ORD was first conjugated with hyaluronic acid (HA) to target the inflammation contributor,pro-inflammatory macrophages.Then,the conjugate assembled onto the MATT-loaded liposomes.The co-loaded system (~150 nm) significantly improved pharmacokinetics over the liposomes without anchoring the conjugate and accumulated effectively in the plaque.The preparation administration allowed efficient anti-AS activities in high-fat diet(HFD)-Apoe-/- mice by decreasing the pro-inflammatory cytokine expression in the serum,lessening the lesion area,alleviating the plaque collagen degradation,promoting macrophage polarization from phenotypic M1 to M2,reducing T helper (Th) 17 cells (Th17)/T regulatory cells (Tregs) and Th1/Th2 ratio, etc.Furthermore,the serum determination in AS patients demonstrated high expression of the inflammatory cytokines,indicating our finding may offer a potential guideline for clinical practice.

    Atherosclerosis (AS) is a chronic inflammatory disease characterized by plaque buildup at the arterial subendothelial space primarily owing to the deposition of activated cells such as macrophages and endothelial cells,lipid and extracellular matrixlike collagen,and glycosaminoglycan [1–4].Clinically,the rupture of the plaque frequently leads to severe cardiovascular events,such as acute myocardial infarction (AMI),stroke,and peripheral arterial disease [5],accounting for 30% of cardiac death worldwide[6].Statin therapy for lipid-lowering is the most commonly used for AS treatment [7,8].However,this regimen has a modest effect on plaque progression [9],and inversely,may increase the risk of coronary heart disease [10].

    Constant inflammation reaction is a vital determinant of plaque development [11].Whereas macrophages,the most abundant leukocytes in the plaque,significantly contribute to inflammation responseviathe production of pro-inflammatory cytokines [12].Unfortunately,single anti-inflammation therapy remains not reduce AS patient mortality [13].Furthermore,the degradation of extracellular plaque-matrix,which disrupts the plaque microenvironment,is another essential factor in promoting plaque advancement[14,15].Collagen constitutes a central portion of the plaque matrix and forms a structural framework under the fibrous cap [16].Viaproviding strength and integrity for the fibrous cap,collagen can protect the plaque from breakup [17].Accordingly,a combined regimen to inhibit decomposition of plaque collagen and suppress inflammationviatargeting plaque macrophages appears to be a promising approach for plaque stabilization.

    Fig.1.Preparation and characterization.(A) Iillustration of the co-loaded pHSLs preparation.(B) Influence of HA-ORD/lipid mass ratio on the pHSLs diameter.(C) FRET between FITC-HA-ORD/Rho-pHSLs with different FITC and Rho mass ratios (excitation wavelength: 430 nm).The HA-ORD was conjugated with FITC,and Rho was loaded in the pHSLs cores.(D) TEM examination.

    Liposomes have been widely used as drug carriers to improve drug delivery due to their various benefits.These include increasing stability through encapsulation,increasing drug efficacy and therapeutic index,improving pharmacokinetic effects (i.e.,decrease elimination and increase circulation lifetime),and reducing the toxicity of encapsulated agents [18,19].This study developed a pH-sensitive liposomal system to co-deliver an anti-inflammatory drug (oridonin,ORD) and a plaque-collagen protector (marimastat,MATT) to the plaque.Briefly,ORD is an anti-inflammatory compound with poor water solubility [20].To improve its solubility and target macrophages,ORD was modified with hyaluronic acid (HA).The HA in the conjugate (HA-ORD) could target cell CD44 receptors [21].MATT,a water-soluble compound,is an effective protector of collagen [22],and MATT could inhibit plaque-collagen degradation by matrix metalloproteinases (MMPs) [23].The pH-sensitive co-delivery liposomes,termed co-loaded pHSLs,were prepared by encapsulating the collagen protector into the aqueous cores and anchoring the conjugate onto the liposomes (Fig.1A).The plaque has an over-metabolism and the resultant acidic microenvironment[24].We proposed that the co-loaded pHSLs could release the two therapeutics in response to the acidic microenvironment after accumulating in the plaque,thereby achieving efficient anti-AS therapy.To obtain proof of concept,we conducted various experimentsin vitroandin vivo.Apoe-/-mice fed with a high-fat diet (HFD)were utilized as a model in the anti-AS studyin vivo.

    The pH-sensitive co-delivery liposomes (co-loaded pHSLs) were prepared by assembling the conjugate HA-ORD onto the MATTloaded pH-sensitive liposomes (MATT-pHSLs) (Fig.1A).First,the targeted conjugate hyaluronic acid-oridonin (HA-ORD) was synthesizedviacondensation reaction.The synthesis of HA-ORD was characterized by1H and13C NMR spectra.Consequently,approximately 70% of fed ORD was linked to HA.Five ORD molecules were involved in one conjugate.MATT-pHSLs were prepared by the film dispersion method and had a diameter of 100–120 nm.Then,the co-loaded pHSLs were prepared by anchoring the hydrophobic section of conjugate onto the liposomesviahydrophobic interactions under ultrasonic conditions.As shown in Fig.1B,the increased proportion of HA-ORD/lipid (w/w) increased the particle size of co-loaded pHSLs from 90 nm to 130 nm.To verify the conjugate loading onto the liposomes,we performed the FRET test by labeling the conjugate with the fluorescence donor (FITC) and encapsulating the fluorescence acceptor (Rho) in the cores of liposomes.As a result of an increase in the mass ratio of FITC/Rho,the maximum intensity of the fluorescence acceptor (Rho) at 575 nm rises gradually,whereas the maximal fluorescence intensity of the donor (FITC) at 515 nm declines (Fig.1C).The results demonstrated the happening of the FRET effect.FRET is always utilized to explore the interaction between two materials by tagging fluorescent donors and acceptors to them [25–27].These results implied the co-assembly of the conjugate and the liposomes.TEM examination displayed the co-loaded pHSLs have a spherical morphology with a 150 nm diameter (Fig.1D).The incubation in 10% serum for 6 h imposed little change on the particle size of MATT-pHSLs and co-loaded pHSLs and,therefore,indicated potential stability in the blood after intravenous injection (Fig.S1 in Supporting information).In addition,little FRET effect between the 6 h incubation liposomes and 0 h incubation samples,implying the two payloads were loaded in the liposomes after serum incubation (Fig.S2 in Supporting information).HPLC assay demonstrated that total drugloading in the co-loaded pHSLs was 8.27% ± 0.19%,wherein the MATT loading was 2.35% ± 0.20% with an encapsulation efficiency of 72.78% ± 6.27%,and while the ORD loading was 6.06%,respectively.After 24 h incubation in 10% serum,the remaining drugs(%) were 98.68% MATT and 99.85% ORD in the co-loaded pHSLs compared with the initial drug loading,demonstrating little drug leakage.The release study depicted that the release of MATT and HA-ORD conjugate from the liposomes at pH 6.0 in first 1 h period was significantly greater than that at pH 7.4 (Fig.S3 in Supporting information,P<0.05),thereby verified the pH-sensitive characteristics of the liposomes.

    To study anti-ASin vitro,we performed various experiments,including M1-like macrophage-targeting,uptake of ox-LDL in macrophages and inflammation inhibition.The accumulation of pro-inflammatory macrophages (M1-like phenotype) promotes the AS pathological process [28].We expected that delivering the targeted anti-inflammatory agent,HA-ORD,to the M1-like macrophages could retard plaque progression through regression of ox-LDL uptake and inflammation activity.First,the targeted uptake of HA-ORD by M1-like macrophages induced by LPS was assayed.The CD44 expression on the M1-like macrophages was verified by confocal imaging after staining with the FITC-CD44 antibody(Fig.S4 in Supporting information).To study the conjugate target ability to the CD44 receptor,we saturated the receptor on the M1-like macrophages by incubation with a high HA-concentration.As shown in Figs.S5A and B (Supporting information),the Rho-HA-ORD uptake in the HA-saturated cells declined significantly(P<0.01).Furthermore,the uptake in the M1-like macrophages was significantly higher than that in nonpolarized RAW264.7(Figs.S5C and D in Supporting information).In addition,the M1-like macrophages uptake was time-related and reached maximal internalization at 2 h post-incubation (Fig.S6 in Supporting information).Overall,the data implied that the conjugate (HA-ORD)could target M1-like macrophages.

    The excessive influx of ox-LDL facilitates the formation of the foam cells and then induces the development of plaques [29].Accordingly,the inhibition of ox-LDL uptake in macrophages functionally impedes AS progress and promotes plaque stability [30,31].As depicted in Figs.S7A and B (Supporting information),the M1-macrophages (LPS-induced RAW264.7) possess improved ability to take up ox-LDL over the nonpolarized RAW264.7 without LPStreatment (Figs.S7A and B,Fig.S8 in Supporting information).The treatment with co-loaded pHSLs restrained the ox-LDL influx with higher efficacy than the incubation with other formulations(Fig.S7B,P<0.001).Furthermore,the anti-inflammatory study indicated that HA-ORD-containing formulations,HA-ORD and coloaded pHSLs,reduced the production of inflammatory cytokines,IL-6 and TNF-α(Figs.S7C and D in Supporting information),while co-loaded pHSLs allowed enhanced anti-inflammation effect.These results demonstrated that co-loaded pHSLs could alleviate ASin vitro.

    Next,we investigated anti-AS efficacyin vivoin theApoe-/-mice with HFD feedviaassaying plaque volume and blood lipid level.After 4 weeks of HFD feeding,theApoe-/-mice were intravenously administrated with different formulations every five days for 8 weeks (Fig.S9A in Supporting information).We first stained descending aorta with oil-red-O (ORO) to assay the lesion area after treatment.As displayed in Figs.S9B and C (Supporting information),combination treatment with the physical mixture or the co-loaded pHSLs reduced the lesion area in the descending aorta compared with the single treatment of free MATT or HA-ORD(P<0.01).Significantly,the dosing of co-loaded pHSLs at low and high doses rendered 0.5 (P<0.05) and 1-fold decrease (P<0.01)in the lesion area over the single administration.Next,we determined the plaque area by staining the aortic sinus cryosection with H&E and ORO (Figs.S9D and E in Supporting information).As showed in H&E and ORO staining,the lesions were inhibited after therapy.The plaque area in the group treated with the co-loaded pHSLs was reduced compared with the groups dosed with the PBS,free HA-ORD,or physical mixture of MATT and HA-ORD (Fig.S9D).The semi-quantitative analysis indicated that the plaque area in groups dosed with PBS,free MATT,free HA-ORD,physical mixture,co-loaded pHSLs at low and high doses was 32.34% ± 1.96%,31.77% ± 0.63%,26.10% ± 3.30%,25.20% ± 2.40%,17.33% ± 4.72%and 12.34% ± 2.11%,respectively (Fig.S9E).The treatment with the co-loaded pHSLs enabled a 1–1.5-fold plaque-area decrease over the PBS treatment.In addition,the mouse weight usually increased during the treatment duration.As a result,no apparent pathologic change after treatment was observed by H&E staining,indicating the safety of these formulations (Figs.S9F and S10 in Supporting information).Overall,the results demonstrated that the therapy with the co-loaded pHSLs could impede plaque advancement effectively.

    Blood lipid is a significant factor contributing to AS progression,including low-density lipoproteins (LDL),cholesterol,high-density lipoproteins (HDL) cholesterol,and other components [32].As reported,the HDL protected the HFD diet animals from AS and,inversely,the LDL is a kind of “bad” cholesterol that its accumulation accelerates the development of AS [33,34].First,we determined the blood lipid levels after dosing.The treatment with the co-loaded pHSLs lowered the serum LDL and total cholesterol(TC) compared with PBS-treatment (P<0.05),accompanied with a modest effect on triglyceride (TG) and HDL (Figs.S11A–D in Supporting information).Next,we calculated the plasma TG/HDL ratio and atherogenic index (common logarithm of TC/HDL ratio).The treatment with co-loaded pHSLs reduced the ratio of TG/HDL and the atherogenic index compared with PBS treatment (Figs.S11E and F in Supporting information,P<0.05).The increase in the TG/HDL ratio and atherogenic index indicates AS exacerbation and a growing risk of cardiovascular events [35].As a result,the coloaded pHSLs administration is promising to attenuate AS by lowering the lipid levels.

    To investigate the contributors to the effective anti-AS effi-cacy,we next studied the pharmacokinetics of co-loaded pHSLs and explored their targetability to the active axis of plaquemicroenvironment components (macrophages and collagen)-inflammatory factors.

    Blood circulation is an essential factor that governs the accumulation of drug carriers in the target site of interest [36,37].And the fluorescence dye was widely used to quantify the pharmacokinetics of carriers,especially the environment-responsive dye,such as aggregation-caused quenching (ACQ) probe [38,39].Furthermore,previous reports demonstrated that the carrier circulation performance obtained by determining the drug was generally similar to fluorescence-dye determination [40].As depicted in Fig.2A,the DiR labeled co-loaded pHSLs displayed significantly higher plasma concentrations at each time point post-injection than DiR-pHSLs without anchoring of HA-ORD.Next,the pharmacokinetic parameters were calculated based plasma concentration(Table S1 in Supporting information).The co-loaded pHSLs demonstrated prolongedt1/2of blood circulation and mean residence time (P<0.05),increased AUC (P<0.05),and lowered clearance rate (CL,P<0.05) in contrast to pHSLs.Therefore,the data indicated that the conjugate (HA-ORD) anchoring enabled prolonged blood circulation time and improved pharmacokinetics.The improved performancein vivoof co-loaded pHSLs may be because the surface HA could offer an extra energy barrier for nanoparticles by presenting bound water molecules and compromising the absorption of opsonin [41,42].

    Then,we first studied the plaque-targeted ability of CF-labeled co-loaded pHSLs in theApoe-/-HFD model.As well known,numerous M1-like macrophages inhabit inside the plaque [43].Accordingly,the plaque targeting was characterized by co-localizing the CF-labeled pHSLs with the M1-like macrophages marked by Cy3 for CD68.As shown in Fig.2B,profound yellow fluorescent spots were exhibited in the group dosed with the CF-labeled pHSLs or co-loaded pHSLs; in contrast,slight yellow fluorescence was observed in the group treated with free dye.Importantly,coloaded pHSLs have more profound co-localization compared with CF-labeled pHSLs.The results demonstrated that the co-loaded pHSLs with HA-ORD anchoring effectively accumulated at the plaque and located inside the lesion area.

    Collagen,a significant component of the plaque extracellular matrix,is critical to stabilizing the plaque and preventing rupture [44].The higher the collagen content,the more stable the plaque [45].Herein,the collagen was identified by Masson staining.As shown in the Masson staining (Fig.2C),the positive collagen stained in blue was demonstrated in the groups treated with MATT-loading preparations,especially with co-loaded pHSLs at low or high doses.Quantified assay indicated that the treatment with co-loaded pHSLs allowed a 1–1.5-fold increase of collagen expression compared to PBS treatment (Fig.2D,P<0.01).Furthermore,co-loaded pHSLs (high dose) demonstrated elevated collagen expression compared to the physical mixture (P<0.05).These results verified that the co-loaded pHSLs could alleviate the plaquecollagen degradation and,therefore,is promising to protect the plaque from disruption.

    To study macrophage polarization switch,we first assayed the polarization pattern of macrophages in the plaque inApoe-/-HFD model after treatment.As depicted in the result of confocal imaging (Fig.3A),a large amount of red fluorescent spots (marking CD68+) and slight green fluorescence (marking CD206+) appeared in the PBS group.Conversely,we observed fewer red fluorescent spots and considerable green fluorescence in the groups administered with HA-ORD loading preparations.Notably,coloaded pHSLs demonstrated elevated green fluorescence intensity compared to the physical mixture (PM) and other preparations.Additional quantified assay indicated that the ratio of CD68+/CD206+macrophages from the groups administered with co-loaded pHSLs at the low or high dose displayed approximately 80% and 40% reduction compared with the PBS- and PMtreated groups,respectively (Fig.3B,P<0.001 andP<0.05).To confirm the phenotype switch of macrophages,we also assayed the M1/M2-like subset in the liver after treatment.The administration of co-loaded pHSLs did not affect the total number of liver macrophages as compared with PBS (Figs.S12A and B in Supporting information),whereas the administration resulted in the expansion of CD206+ macrophages and reduction of CD68+phenotype (Figs.S12C and D in Supporting information,P<0.05).

    Fig.2.Pharmacokinetics,plaque targeting and collagen in the lesion area.(A) Pharmacokinetics of pHSLs and co-loaded pHSLs.DiR labeled formulations were intravenously injected at a DiR dose of 5 mg/kg,according to the body weight.The fluorescence intensity was detected by a microplate reader at 748 nm (excitation) and 780 nm(emission). n=5.(B) Targeting the plaque in Apoe-/- HFD mice.The tricuspid ring of the mouse heart was isolated for sectioning after 2 h injection with CF-labeled formulations and the control (free CF) via the tail vein at a CF dose of 2.5 mg/kg,according to the body weight.The plaque was marked by labeling the CD68 on macrophages with Cy3 (red,5 μg/mL).Scale bar: 50 μm.(C) Masson staining of the descending aortas after administration.The collagen fibers were stained to blue and muscle fibers to red.The plaque was stained to red.The dosage of ORD and MATT in the pHSLs was 5/5 mg/kg and 5/10 mg/kg for low dose and high dose,respectively.(D) Semi-quantitative of collagen in the plaque calculated by ImageJ.pHSLs herein were the co-loaded pHSLs.Scale bar: 200 μm. n=3,*P<0.05,**P<0.01,compared with saline; #P<0.05,compared with free MATT; ns,not significant.

    Fig.3.Targeting macrophages and ameliorating inflammation.(A) Analysis of macrophages by immunofluorescence staining and (B) semi-quantitative of the M1/M2 ratio by ImageJ.M1 macrophages (CD68) were stained to red with Cy3-labeled second antibody,and M2 macrophages (CD206) were stained to green with FITC-labeled second antibody.Scale bar: 20 μm.(C–E) The inflammatory cytokines expression in the serum.IL-6 and TNF-α were measured using the Bio-Plex? multiplex array systems.IL-22 was determined with ELISA kits.The dosage for ORD and MATT was 5 mg/kg.The low dose and high dose indicate the different dosages of co-loaded pHSLs,5/5 mg/kg and 5/10 mg/kg for ORD and MATT. n=3,*P<0.05,**P<0.01,***P<0.001,compared with saline; #P<0.05,##P<0.01,compared with free HA-ORD,free MATT or physical mixture; ns,not significant.

    In addition,we detected the immune cells,T regulatory cells(Tregs) and T-lymphocyte helper (Th) cells,in the serum,owing to that Tregs could inhibit inflammation and AS progression,while the increased ratio of Th17/Tregs and Th1/Th2 always exacerbate inflammation and atherogenesis [46–48].As displayed in Figs.S13A–D (Supporting information),dosing the co-loaded pHSLs at low or high dose demonstrated limited influence on the Treg percent and,while reducing the ratio of Th17/Tregs (P<0.05)and Th1/Th2 (P<0.01) compared with PBS administration.Overall,the data revealed the treatment with co-loaded pHSLs regressed macrophage polarization switch towards pro-inflammatory phenotype in the plaque and livers and decreased the ratio of Th1/Tregs and Th1/Th2,which could benefit the plaque stabilization [49].

    Finally,the inflammatory serum cytokines were measured after treatment.The pro-inflammatory factors,IL-6,IL-22,and TNFα,were significantly downregulated after treatment with HA-ORD loading preparations,including free HA-ORD,PM,and co-loaded pHSLs,compared with PBS treatment (Figs.3C–E,P<0.001).Especially,the dosing of co-loaded pHSLs at a high dose reduced the levels of IL-6 and IL-22 by 3- and 1.5-fold,respectively,over PM treatment (Figs.3C–E).The data implied that the treatment with co-loaded pHSLs could lessen the inflammation.

    To confirm the present results that might provide potential guidelines for the clinical treatment,we further tested the serum cytokines in patients with acute myocardial infarction (AMI)caused by the rupture of AS plaque [50] and healthy volunteers without cardiovascular disease.The population baseline table is shown in Table S2 (Supporting information).As displayed in Fig.S14 (Supporting information),elevated inflammatory cytokines,IL-6,IL-22,and TNF-α,were demonstrated in the patients compared with the healthy volunteers (P<0.001).The data indicated that our results could be translated into the clinic practices of AS therapy.

    Taken together,we proved that the co-loaded pHSLs had extended blood circulation time,effectively accumulated in the plaque,facilitated macrophage polarization into M2-like phenotype,and rendered inhibition of both inflammation and collagen degradation (Fig.S15 in Supporting information).Furthermore,their administration to HFD-Apoe-/-mice reduced the lesion area,elevated the percent of Tregs,decreased the Th1/Th2 ratio.Targeted co-delivery of inflammation inhibitor and collagen protector to the plaque represents a promising approach for anti-AS therapy.

    The anchoring strategy developed here acts as a promising approach to load a polymer-based conjugate/prodrug in liposomes to improve delivery.The conjugate HA-ORD with a molecular weight of over 10,000 Da is challenging to be loaded in liposome core or lipid bilayer.Rather than loading the conjugate at the two locations,we loaded it on liposomes by the anchoring strategy that the hydrophobic section in conjugate inserted into the liposome’s lipid membrane.Furthermore,the anchoring improved the pharmacokinetic performance of the pHSLs.In addition,the anchoring facilitated plaque accumulation of the co-loaded pHSLs because HA on the co-loaded pHSLs could target the CD44 receptors that are overexpressed on the cells inhabiting the plaques.The CD44 receptors in the plaque have>10-fold increase over that in healthy vascular tissue [51].Nonetheless,the plaque targeting-efficacy of drug delivery systems is correlated with plaque advancement [52].Additional study is needed to clarify the targetability of the co-loaded pHSLs to the early and advanced plaque.

    The features,including thin fibrous cap,inflammation,accumulation of inflammatory cells,and raised blood lipid levels are closely linked to the rupture of the plaque [53].Significantly,the loss of fibrillar collagen is a direct cause to make the fibrous cap become thinning [54].In this study,we found that the targeting co-delivery of the collagen protector MATT and antiinflammatory HA-ORD conjugate using pHSLs to the plaque relieved the degradation of plaque collagen,reduced the accumulation of M1-like macrophages,alleviated inflammation,and declined the blood level.These indicators confirmed that the coloaded pHSLs could stabilize the rupture-prone plaque in HFDApoe-/-mice.Furthermore,we found that the plaque was regressed,as evidenced by dosing the co-loaded pHSLs to HFDApoe-/-mice reduced the plaque area by 1–1.5-fold compared to the PBS treatment.The plaque regression may be ascribed to the lowering of blood lipids,LDL and TC,and reduced residence of proinflammatory macrophages after administration of co-loaded pHSLs [55].

    IL-6 plays a leading role in the inflammatory progressions underlying cardiovascular diseases [28,56],and meanwhile,TNF-αfacilitates the development of plaque at all stages [12,57].Herein,we demonstrated that treatment with the co-loaded pHSLs significantly reduced the IL-6,IL-22,and TNF-αin HFD-Apoe-/-mice(Figs.3C–E).The data is consistent with the serum determination from the AS patients,in which the two indicators markedly upregulated,as displayed in Fig.S14.As a result,our data may inspire the clinic treatment of AS,which is combinatorial use of antiinflammatory drugs and collagen protectors to improve AS therapy.

    In summary,the co-loaded pHSLs allowed effective anti-AS therapy by targeted co-delivery of the anti-inflammatory (HA-ORD)and collagen protector (MATT) to the plaque.Moreover,the targeted co-delivery suppressed plaque regression.Besides promoting macrophage polarization into M2-like phenotype and alleviating inflammation and plaque-collagen degradation,we confirmed that the co-delivery could lower the blood lipid level and modulate the immune-cell ratio of Th17/Tregs and Th1/Th2 as well.We believe the current liposomal strategy is promising to target the AS plaque.Targeted co-delivery of anti-inflammatory drugs and collagen protectors to the plaque represents an efficient regimen to treat AS.The finding may provide a potential guideline for the clinic practices of AS treatment.

    MATT utilized in the study was a broad-spectrum MMP inhibitor and was not approved for clinical use.However,Periostat,an MMP inhibitor,has been permitted clinically [58].Accordingly,the combinatorial use of an anti-inflammatory drug and Periostat has the potential as an AS therapy regimen.

    Declaration of competing interest

    The authors have no conflicts of interest to declare.

    Acknowledgments

    This study was supported by the National Natural Science Foundation of China (Nos.81872823,82073782,81970374),the Shanghai Science and Technology Committee (No.19430741500).We are thankful for the guidance and help provided by Lab Center,the Second Affiliated Hospital of Nanjing Medical University.

    Supplementary materials

    Supplementary material associated with this article can be found,in the online version,at doi:10.1016/j.cclet.2022.04.081.

    91成人精品电影| 狠狠精品人妻久久久久久综合| 观看av在线不卡| 性高湖久久久久久久久免费观看| 狠狠精品人妻久久久久久综合| 久久韩国三级中文字幕| 五月伊人婷婷丁香| 插逼视频在线观看| 热re99久久精品国产66热6| 亚洲情色 制服丝袜| 日韩中字成人| 午夜福利在线观看免费完整高清在| 美女中出高潮动态图| 亚洲欧美清纯卡通| 一边亲一边摸免费视频| 国产精品国产三级专区第一集| 色5月婷婷丁香| 一个人免费看片子| 国产亚洲精品久久久com| 中国三级夫妇交换| 国产亚洲5aaaaa淫片| 岛国毛片在线播放| 在线观看人妻少妇| 熟女人妻精品中文字幕| 男女国产视频网站| 国产片特级美女逼逼视频| 久久精品国产亚洲av涩爱| 亚洲欧美日韩另类电影网站| 卡戴珊不雅视频在线播放| 亚洲精品色激情综合| 一级毛片黄色毛片免费观看视频| 亚洲国产精品999| 久久人人爽人人片av| av国产精品久久久久影院| 在线观看三级黄色| 一级,二级,三级黄色视频| 黄色一级大片看看| 精品一区二区三卡| 一级av片app| 精品卡一卡二卡四卡免费| 十分钟在线观看高清视频www | 日日啪夜夜爽| 狂野欧美白嫩少妇大欣赏| 一区二区三区四区激情视频| 日本vs欧美在线观看视频 | 日日爽夜夜爽网站| 色吧在线观看| 日本色播在线视频| 午夜福利在线观看免费完整高清在| 91精品一卡2卡3卡4卡| 久久精品国产亚洲av天美| 国产片特级美女逼逼视频| 男男h啪啪无遮挡| 大码成人一级视频| 中文欧美无线码| 精品国产一区二区三区久久久樱花| 蜜桃在线观看..| 亚洲av不卡在线观看| 狂野欧美白嫩少妇大欣赏| 国语对白做爰xxxⅹ性视频网站| 国精品久久久久久国模美| av一本久久久久| 欧美国产精品一级二级三级 | 男人和女人高潮做爰伦理| 午夜福利视频精品| 免费大片18禁| 欧美精品国产亚洲| 菩萨蛮人人尽说江南好唐韦庄| 亚洲精品日韩在线中文字幕| 男女免费视频国产| 国产精品.久久久| 久久毛片免费看一区二区三区| 精品久久久久久电影网| 国产精品一区二区三区四区免费观看| 久久精品熟女亚洲av麻豆精品| 欧美日韩亚洲高清精品| 黄色视频在线播放观看不卡| 女性被躁到高潮视频| 卡戴珊不雅视频在线播放| 丰满迷人的少妇在线观看| 国产成人精品婷婷| 最近最新中文字幕免费大全7| 3wmmmm亚洲av在线观看| 成年美女黄网站色视频大全免费 | 一级黄片播放器| 亚洲精品国产成人久久av| 美女国产视频在线观看| 少妇丰满av| 久久免费观看电影| 天天操日日干夜夜撸| 九草在线视频观看| 日韩成人伦理影院| 国产又色又爽无遮挡免| 熟妇人妻不卡中文字幕| 成年av动漫网址| 一本久久精品| 国产成人精品无人区| 亚洲av电影在线观看一区二区三区| 成人黄色视频免费在线看| 亚洲美女黄色视频免费看| 成人黄色视频免费在线看| 精品久久久久久久久亚洲| 99热国产这里只有精品6| 欧美bdsm另类| 日本wwww免费看| 亚洲一级一片aⅴ在线观看| 日韩制服骚丝袜av| 亚洲怡红院男人天堂| 十分钟在线观看高清视频www | 亚洲婷婷狠狠爱综合网| 午夜老司机福利剧场| 国产在视频线精品| 2021少妇久久久久久久久久久| 中文乱码字字幕精品一区二区三区| 中文字幕精品免费在线观看视频 | 插逼视频在线观看| 欧美三级亚洲精品| 亚洲欧美精品自产自拍| 三级国产精品欧美在线观看| 久久久久久久久久久久大奶| 伊人亚洲综合成人网| 婷婷色麻豆天堂久久| 亚洲av国产av综合av卡| 国产 一区精品| 日本午夜av视频| 美女主播在线视频| 搡女人真爽免费视频火全软件| 九九久久精品国产亚洲av麻豆| 99久久中文字幕三级久久日本| 久久人人爽人人爽人人片va| 亚洲国产欧美在线一区| 最近最新中文字幕免费大全7| 五月玫瑰六月丁香| 国产成人精品婷婷| 免费av中文字幕在线| 男女国产视频网站| 搡老乐熟女国产| 国国产精品蜜臀av免费| 欧美国产精品一级二级三级 | 免费看日本二区| 晚上一个人看的免费电影| 欧美日韩亚洲高清精品| 婷婷色av中文字幕| 亚洲精品456在线播放app| 99热全是精品| 秋霞在线观看毛片| 国产精品蜜桃在线观看| 精品99又大又爽又粗少妇毛片| 香蕉精品网在线| 美女视频免费永久观看网站| 久久人人爽人人片av| 亚洲欧美日韩另类电影网站| 少妇 在线观看| 欧美xxxx性猛交bbbb| 狂野欧美白嫩少妇大欣赏| 美女视频免费永久观看网站| 男人狂女人下面高潮的视频| 欧美3d第一页| 51国产日韩欧美| 日韩欧美精品免费久久| av在线播放精品| 一区二区三区四区激情视频| 9色porny在线观看| 久久ye,这里只有精品| 天美传媒精品一区二区| 高清不卡的av网站| 日韩免费高清中文字幕av| 免费观看的影片在线观看| 国产免费一区二区三区四区乱码| 大片免费播放器 马上看| 高清欧美精品videossex| 中文字幕精品免费在线观看视频 | 欧美日韩亚洲高清精品| 嘟嘟电影网在线观看| 中文字幕免费在线视频6| av线在线观看网站| 99热这里只有是精品50| 久久久精品免费免费高清| 秋霞伦理黄片| 久久久精品免费免费高清| 亚洲丝袜综合中文字幕| 赤兔流量卡办理| 日韩成人伦理影院| 精品酒店卫生间| 日本-黄色视频高清免费观看| 边亲边吃奶的免费视频| 黄片无遮挡物在线观看| 亚洲熟女精品中文字幕| 久久精品国产自在天天线| 一本—道久久a久久精品蜜桃钙片| 一边亲一边摸免费视频| 亚洲精品国产成人久久av| 啦啦啦中文免费视频观看日本| 一区二区三区四区激情视频| 成人无遮挡网站| 精品人妻熟女av久视频| 青春草国产在线视频| 欧美成人精品欧美一级黄| 中文字幕人妻熟人妻熟丝袜美| 精品一区二区三卡| 亚洲精品一二三| av福利片在线观看| 制服丝袜香蕉在线| 久久免费观看电影| 一本—道久久a久久精品蜜桃钙片| 国产精品秋霞免费鲁丝片| 3wmmmm亚洲av在线观看| 国产一区亚洲一区在线观看| 精品一区在线观看国产| 久久国产亚洲av麻豆专区| 在现免费观看毛片| 天堂俺去俺来也www色官网| 91精品国产九色| tube8黄色片| 亚洲精华国产精华液的使用体验| 国产探花极品一区二区| 99视频精品全部免费 在线| 国产永久视频网站| 一区在线观看完整版| 久久久久久久久大av| 国国产精品蜜臀av免费| 美女福利国产在线| 欧美日韩av久久| 国产精品久久久久久精品古装| 极品少妇高潮喷水抽搐| 欧美变态另类bdsm刘玥| 成人亚洲精品一区在线观看| 成人亚洲欧美一区二区av| 22中文网久久字幕| 这个男人来自地球电影免费观看 | 夜夜看夜夜爽夜夜摸| 久久久午夜欧美精品| 国内少妇人妻偷人精品xxx网站| 国产有黄有色有爽视频| 日韩一本色道免费dvd| 欧美三级亚洲精品| 久久国产精品大桥未久av | 欧美精品国产亚洲| 国精品久久久久久国模美| 18禁在线播放成人免费| 亚洲情色 制服丝袜| 一本久久精品| 在现免费观看毛片| 青春草国产在线视频| 啦啦啦啦在线视频资源| 最近2019中文字幕mv第一页| 青春草国产在线视频| 99久久人妻综合| 丝瓜视频免费看黄片| 91精品一卡2卡3卡4卡| 欧美日本中文国产一区发布| 久久久亚洲精品成人影院| 亚洲精品久久久久久婷婷小说| 久久国产乱子免费精品| 一边亲一边摸免费视频| 亚洲精品国产成人久久av| 人体艺术视频欧美日本| 人人妻人人看人人澡| 伊人久久精品亚洲午夜| 91久久精品电影网| 22中文网久久字幕| 久久国产乱子免费精品| 少妇的逼好多水| 日韩大片免费观看网站| 国产一区亚洲一区在线观看| 菩萨蛮人人尽说江南好唐韦庄| 在线观看国产h片| 亚洲欧洲日产国产| 少妇被粗大猛烈的视频| 久久久国产一区二区| 亚洲国产欧美在线一区| 哪个播放器可以免费观看大片| 国产精品国产三级专区第一集| 亚洲av成人精品一二三区| 久久久国产一区二区| 亚洲精品自拍成人| 国产免费福利视频在线观看| 亚洲国产毛片av蜜桃av| 亚洲性久久影院| 色5月婷婷丁香| 亚洲成人av在线免费| 一区二区三区精品91| 日韩av在线免费看完整版不卡| 久久久午夜欧美精品| 我的女老师完整版在线观看| 国产精品秋霞免费鲁丝片| 一本色道久久久久久精品综合| 午夜av观看不卡| 一级片'在线观看视频| 黑人猛操日本美女一级片| 日韩中文字幕视频在线看片| 中文字幕av电影在线播放| 好男人视频免费观看在线| 少妇猛男粗大的猛烈进出视频| 亚洲av免费高清在线观看| 下体分泌物呈黄色| 亚洲国产成人一精品久久久| 少妇被粗大的猛进出69影院 | 国产一区有黄有色的免费视频| 欧美老熟妇乱子伦牲交| 中文天堂在线官网| 国产国拍精品亚洲av在线观看| 热re99久久国产66热| 免费av中文字幕在线| 久久久久精品性色| 国产精品不卡视频一区二区| 久久久亚洲精品成人影院| xxx大片免费视频| 亚洲婷婷狠狠爱综合网| 亚洲人成网站在线播| 国产日韩欧美亚洲二区| 精品少妇黑人巨大在线播放| 熟女电影av网| 26uuu在线亚洲综合色| 2018国产大陆天天弄谢| 99久国产av精品国产电影| 在线亚洲精品国产二区图片欧美 | av线在线观看网站| 97超碰精品成人国产| 人体艺术视频欧美日本| 久久久午夜欧美精品| 亚洲天堂av无毛| 爱豆传媒免费全集在线观看| 欧美性感艳星| videossex国产| 超碰97精品在线观看| 青春草视频在线免费观看| 欧美日韩一区二区视频在线观看视频在线| av网站免费在线观看视频| 大片电影免费在线观看免费| 美女内射精品一级片tv| 亚洲成人一二三区av| 精品一区二区三卡| 天天躁夜夜躁狠狠久久av| 五月玫瑰六月丁香| 欧美 亚洲 国产 日韩一| 亚洲国产欧美日韩在线播放 | 欧美成人午夜免费资源| 高清视频免费观看一区二区| 亚洲国产精品一区二区三区在线| 99久久中文字幕三级久久日本| 日本av手机在线免费观看| 日本黄色片子视频| 99久久精品一区二区三区| 天天操日日干夜夜撸| 爱豆传媒免费全集在线观看| av女优亚洲男人天堂| 国产日韩欧美在线精品| 国产精品偷伦视频观看了| 美女xxoo啪啪120秒动态图| 建设人人有责人人尽责人人享有的| 国产日韩欧美在线精品| 日韩熟女老妇一区二区性免费视频| 欧美精品一区二区免费开放| 精品久久国产蜜桃| 亚洲成人手机| 国产精品一二三区在线看| 午夜福利,免费看| 免费高清在线观看视频在线观看| 久久ye,这里只有精品| 少妇人妻精品综合一区二区| 欧美变态另类bdsm刘玥| 日本黄大片高清| 亚洲婷婷狠狠爱综合网| 国产色爽女视频免费观看| 亚洲精品aⅴ在线观看| 18禁裸乳无遮挡动漫免费视频| 成年人午夜在线观看视频| 久久久精品免费免费高清| 国产熟女欧美一区二区| 免费不卡的大黄色大毛片视频在线观看| 欧美日韩国产mv在线观看视频| 观看免费一级毛片| 亚洲欧美精品自产自拍| 高清av免费在线| 一本大道久久a久久精品| 一级毛片aaaaaa免费看小| 免费观看在线日韩| 亚洲自偷自拍三级| 国产av国产精品国产| 欧美成人精品欧美一级黄| 亚洲av二区三区四区| 国产真实伦视频高清在线观看| 久久国产亚洲av麻豆专区| 色视频www国产| 日日啪夜夜爽| av专区在线播放| 少妇被粗大的猛进出69影院 | 卡戴珊不雅视频在线播放| 色视频www国产| 国产精品99久久久久久久久| 精华霜和精华液先用哪个| 伦理电影免费视频| 日韩免费高清中文字幕av| 97超视频在线观看视频| 交换朋友夫妻互换小说| 在线观看www视频免费| 免费播放大片免费观看视频在线观看| 男女无遮挡免费网站观看| 亚洲欧美日韩东京热| 日本色播在线视频| 成人漫画全彩无遮挡| 午夜激情福利司机影院| 在线观看免费视频网站a站| 国产av码专区亚洲av| 少妇人妻久久综合中文| 亚洲综合精品二区| 久久久久久久久久久丰满| 免费大片黄手机在线观看| 国产一区二区在线观看日韩| 久久久久久久精品精品| 国产精品久久久久久精品古装| 国产毛片在线视频| 国产精品国产三级专区第一集| 多毛熟女@视频| 久久久久精品性色| 成人午夜精彩视频在线观看| 天天躁夜夜躁狠狠久久av| 一级毛片电影观看| 日韩 亚洲 欧美在线| 日韩精品免费视频一区二区三区 | 亚洲国产日韩一区二区| av免费观看日本| 六月丁香七月| 免费看日本二区| av.在线天堂| 69精品国产乱码久久久| av天堂久久9| 99热这里只有是精品在线观看| 久久亚洲国产成人精品v| 在线观看免费日韩欧美大片 | 日本与韩国留学比较| 噜噜噜噜噜久久久久久91| 三级国产精品片| 亚洲欧美成人精品一区二区| 亚洲精品日韩av片在线观看| av国产精品久久久久影院| 久久久久久久亚洲中文字幕| 男女啪啪激烈高潮av片| 久久久久人妻精品一区果冻| 性色av一级| 欧美激情极品国产一区二区三区 | 国产精品久久久久久精品电影小说| av黄色大香蕉| 免费av不卡在线播放| 午夜久久久在线观看| 日韩一区二区三区影片| 波野结衣二区三区在线| 我的女老师完整版在线观看| 老司机亚洲免费影院| 国产成人午夜福利电影在线观看| 22中文网久久字幕| 91成人精品电影| 国产成人午夜福利电影在线观看| 亚洲精品日韩在线中文字幕| 高清不卡的av网站| 十八禁高潮呻吟视频 | 最近中文字幕高清免费大全6| 成人二区视频| 天堂中文最新版在线下载| 男女边吃奶边做爰视频| 亚洲精品日本国产第一区| 两个人免费观看高清视频 | 天堂8中文在线网| 国产欧美日韩一区二区三区在线 | 欧美老熟妇乱子伦牲交| 男人舔奶头视频| 天堂8中文在线网| 亚洲国产成人一精品久久久| 色网站视频免费| 18禁裸乳无遮挡动漫免费视频| 麻豆成人午夜福利视频| 在线播放无遮挡| 搡女人真爽免费视频火全软件| 久久午夜福利片| 丝袜喷水一区| 寂寞人妻少妇视频99o| 欧美另类一区| 亚洲精品456在线播放app| 女人久久www免费人成看片| 亚洲av男天堂| 中文乱码字字幕精品一区二区三区| 午夜免费男女啪啪视频观看| 26uuu在线亚洲综合色| 99久久综合免费| 久久久国产欧美日韩av| 边亲边吃奶的免费视频| 日韩中文字幕视频在线看片| 欧美精品亚洲一区二区| 久久久久久久久久成人| 亚洲欧洲国产日韩| 热99国产精品久久久久久7| 午夜视频国产福利| 免费观看a级毛片全部| 最近手机中文字幕大全| a级一级毛片免费在线观看| 日本av免费视频播放| 久久韩国三级中文字幕| 乱码一卡2卡4卡精品| 久久久亚洲精品成人影院| 一级毛片久久久久久久久女| 乱人伦中国视频| 亚洲av日韩在线播放| 欧美性感艳星| 老熟女久久久| 国内少妇人妻偷人精品xxx网站| 国产综合精华液| 国产91av在线免费观看| 男的添女的下面高潮视频| 99九九在线精品视频 | 亚洲av中文av极速乱| 成人漫画全彩无遮挡| 久久韩国三级中文字幕| 一级毛片aaaaaa免费看小| 久久99一区二区三区| 午夜免费鲁丝| 国产日韩欧美在线精品| 亚洲精品亚洲一区二区| 免费观看性生交大片5| av在线老鸭窝| 日本与韩国留学比较| 日韩欧美精品免费久久| 久久毛片免费看一区二区三区| 婷婷色综合大香蕉| 老司机影院成人| 欧美激情国产日韩精品一区| av免费在线看不卡| 最近2019中文字幕mv第一页| 欧美日本中文国产一区发布| 日韩大片免费观看网站| 欧美3d第一页| 日本-黄色视频高清免费观看| 国产视频首页在线观看| av在线app专区| 国产免费福利视频在线观看| 成人漫画全彩无遮挡| 女的被弄到高潮叫床怎么办| 你懂的网址亚洲精品在线观看| 91久久精品国产一区二区三区| 中文字幕亚洲精品专区| 男的添女的下面高潮视频| 久久99热这里只频精品6学生| 免费黄频网站在线观看国产| 哪个播放器可以免费观看大片| 高清欧美精品videossex| 亚洲欧美成人精品一区二区| 一本—道久久a久久精品蜜桃钙片| 韩国av在线不卡| 精品国产露脸久久av麻豆| 免费大片18禁| 又黄又爽又刺激的免费视频.| 午夜日本视频在线| 午夜老司机福利剧场| 亚洲人成网站在线观看播放| 国产成人91sexporn| 热re99久久精品国产66热6| 永久网站在线| 美女福利国产在线| 久久久精品免费免费高清| 国内揄拍国产精品人妻在线| 下体分泌物呈黄色| 麻豆成人av视频| 自拍欧美九色日韩亚洲蝌蚪91 | 国产69精品久久久久777片| 天堂中文最新版在线下载| 亚洲,一卡二卡三卡| 少妇的逼水好多| 亚洲av男天堂| 嘟嘟电影网在线观看| 亚洲欧美一区二区三区黑人 | 日韩熟女老妇一区二区性免费视频| 久久久国产一区二区| 内地一区二区视频在线| 国产黄频视频在线观看| 国产精品嫩草影院av在线观看| 日韩熟女老妇一区二区性免费视频| 日本猛色少妇xxxxx猛交久久| 女的被弄到高潮叫床怎么办| 中文天堂在线官网| 六月丁香七月| 国产精品99久久久久久久久| 七月丁香在线播放| 久久精品国产亚洲av天美| 免费高清在线观看视频在线观看| av卡一久久| 国产高清不卡午夜福利| 嫩草影院新地址| 少妇高潮的动态图| 一级毛片久久久久久久久女| 人人妻人人爽人人添夜夜欢视频 | 伦理电影免费视频| 国产高清三级在线| 国产成人91sexporn| 夜夜爽夜夜爽视频| 看非洲黑人一级黄片| 天堂俺去俺来也www色官网| 久久久久久久久久人人人人人人| 伦理电影免费视频| 99热这里只有是精品50| 亚洲伊人久久精品综合| 精品亚洲成a人片在线观看| 26uuu在线亚洲综合色| 嘟嘟电影网在线观看| 国产真实伦视频高清在线观看| 简卡轻食公司| 亚洲第一区二区三区不卡| 麻豆成人午夜福利视频| 美女脱内裤让男人舔精品视频| 精品少妇内射三级| 日本黄色日本黄色录像| 国产精品一区二区在线不卡| 男人添女人高潮全过程视频| 午夜激情久久久久久久| 免费黄频网站在线观看国产| 91久久精品电影网|